Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Su Zhao

Showing results (201-210 of 234) with videos related to

Pageof 24
Sort By:
Haematologica|October 12, 2023
Targeting T<sub>FH</sub> cells is a novel approach for donor-specific antibody desensitization of allograft candidates: an <i>in vitro</i> and <i>in vivo</i> studyNing Ma, Wei-Bing Wu, Xiang-Yu Zhao, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 16, 2020
Human herpesvirus 6 reactivation in unmanipulated haploidentical hematopoietic stem cell transplantation predicts the occurrence of grade II to IV acute graft-versus-host diseaseTing-Ting Han, Yi-Ning Zhang, Yu-Qian Sun, et al.
HLA|June 10, 2022
Prevalence and risk factors of antibodies to HLA according to different cut-off values of mean fluorescence intensity in haploidentical allograft candidates: A prospective study of 3805 subjectsNing Ma, Jia-Pei Guo, Xiang-Yu Zhao, et al.
Journal of Hematology & Oncology|February 8, 2017
The dynamics of RUNX1-RUNX1T1 transcript levels after allogeneic hematopoietic stem cell transplantation predict relapse in patients with t(8;21) acute myeloid leukemiaYa-Zhen Qin, Yu Wang, Lan-Ping Xu, et al.
Journal of Hematology & Oncology|July 10, 2015
Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation setsYing-Jun Chang, Xiang-Yu Zhao, Lan-Ping Xu, et al.
Clinical and Experimental Medicine|May 13, 2026
Ultra-Low BCR::ABL1 positivity by digital PCR does not improve post-transplant risk stratification beyond real-time PCR in Ph+ acute lymphoblastic leukemia post-transplantYa Luo, Wen-Min Chen, Xiao-Su Zhao, et al.
Blood Science (Baltimore, Md.)|September 27, 2024
Pre-transplantation levels of lysine (K)-specific methyltransferase 2A (<i>KMT2A</i>) partial tandem duplications can predict relapse of acute myeloid leukemia patients following haploidentical donor hematopoietic stem cell transplantationDao-Xing Deng, Xiao-Hang Ma, Ze-Hua Wu, et al.
Bone Marrow Transplantation|April 6, 2026
Second alternative-donor haploidentical stem cell transplantation enhances survival in patients with myeloid malignancies complicated by posttransplant human leukocyte antigen loss relapseXiao-Tong Chen, Ze-Chang Shi, Yu Wang, et al.
Clinical and Experimental Immunology|May 13, 2022
CMV infection combined with acute GVHD associated with poor CD8+ T-cell immune reconstitution and poor prognosis post-HLA-matched allo-HSCTZe-Ying Fan, Ting-Ting Han, Wei Zuo, et al.
British Journal of Haematology|November 17, 2021
Donor activating killer cell immunoglobulin-like receptors genes correlated with Epstein-Barr virus reactivation after haploidentical haematopoietic stem cell transplantationXiang Wang, Xue-Fei Liu, Qian-Nan Shang, et al.
Pageof 24

Showing results (201-210 of 234) with videos related to

Sort By:
Pageof 24
Haematologica|October 12, 2023
Targeting T<sub>FH</sub> cells is a novel approach for donor-specific antibody desensitization of allograft candidates: an <i>in vitro</i> and <i>in vivo</i> studyNing Ma, Wei-Bing Wu, Xiang-Yu Zhao, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 16, 2020
Human herpesvirus 6 reactivation in unmanipulated haploidentical hematopoietic stem cell transplantation predicts the occurrence of grade II to IV acute graft-versus-host diseaseTing-Ting Han, Yi-Ning Zhang, Yu-Qian Sun, et al.
HLA|June 10, 2022
Prevalence and risk factors of antibodies to HLA according to different cut-off values of mean fluorescence intensity in haploidentical allograft candidates: A prospective study of 3805 subjectsNing Ma, Jia-Pei Guo, Xiang-Yu Zhao, et al.
Journal of Hematology & Oncology|February 8, 2017
The dynamics of RUNX1-RUNX1T1 transcript levels after allogeneic hematopoietic stem cell transplantation predict relapse in patients with t(8;21) acute myeloid leukemiaYa-Zhen Qin, Yu Wang, Lan-Ping Xu, et al.
Journal of Hematology & Oncology|July 10, 2015
Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation setsYing-Jun Chang, Xiang-Yu Zhao, Lan-Ping Xu, et al.
Clinical and Experimental Medicine|May 13, 2026
Ultra-Low BCR::ABL1 positivity by digital PCR does not improve post-transplant risk stratification beyond real-time PCR in Ph+ acute lymphoblastic leukemia post-transplantYa Luo, Wen-Min Chen, Xiao-Su Zhao, et al.
Blood Science (Baltimore, Md.)|September 27, 2024
Pre-transplantation levels of lysine (K)-specific methyltransferase 2A (<i>KMT2A</i>) partial tandem duplications can predict relapse of acute myeloid leukemia patients following haploidentical donor hematopoietic stem cell transplantationDao-Xing Deng, Xiao-Hang Ma, Ze-Hua Wu, et al.
Bone Marrow Transplantation|April 6, 2026
Second alternative-donor haploidentical stem cell transplantation enhances survival in patients with myeloid malignancies complicated by posttransplant human leukocyte antigen loss relapseXiao-Tong Chen, Ze-Chang Shi, Yu Wang, et al.
Clinical and Experimental Immunology|May 13, 2022
CMV infection combined with acute GVHD associated with poor CD8+ T-cell immune reconstitution and poor prognosis post-HLA-matched allo-HSCTZe-Ying Fan, Ting-Ting Han, Wei Zuo, et al.
British Journal of Haematology|November 17, 2021
Donor activating killer cell immunoglobulin-like receptors genes correlated with Epstein-Barr virus reactivation after haploidentical haematopoietic stem cell transplantationXiang Wang, Xue-Fei Liu, Qian-Nan Shang, et al.
Pageof 24